Time filter

Source Type

Patent
Sun Pharma Advanced Research Company Ltd | Date: 2016-09-30

The present invention relates to a process for the preparation of unilamellar liposomal composition of a polyene antibiotic drug. The present invention further relates to liposomal composition of a polyene antibiotic drug that is stable.


Patent
SUN PHARMA ADVANCED RESEARCH Co. | Date: 2016-02-12

A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.


Patent
Sun Pharma Advanced Research Company Ltd | Date: 2017-04-05

The present invention relates to a process for the preparation of unilamellar liposomal composition of a polyene antibiotic drug. The present invention further relates to liposomal composition of a polyene antibiotic drug that is stable.


Patent
SUN PHARMA ADVANCED RESEARCH Co. | Date: 2015-03-25

An abuse deterrent immediate release coated reservoir solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.


Patent
Sun Pharma Advanced Research Company | Date: 2014-10-31

The present invention relates to novel carbamate intermediate of formula (II), process for its preparation and process for its conversion into 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol, tapentadol and its pharmaceutically acceptable salts.


The present invention relates to methods of treatment of inflammatory conditions using S-[4-(3-fluoro-3-methylbutyryloxy)-but-2-ynyl]6,9-difluoro-17-(furan-2-yl)carbonyloxy-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carbothioate (compound of formula I), a novel anti-inflammatory compound of the androstane series and its processes of preparation.


Patent
SUN PHARMA ADVANCED RESEARCH Co. | Date: 2015-03-25

An abuse deterrent immediate release biphasic matrix solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.


Patent
Sun Pharma Advanced Research Company Ltd | Date: 2015-04-01

The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more taxane derivative, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts.


Patent
Sun Pharma Advanced Research Company | Date: 2015-04-20

The present invention relates to a pharmaceutical composition suitable for ophthalmic use comprising one or more prostaglandin derivatives or salts, a stabilizing amount of polyethylene glycol hydroxystearate and pharmaceutically acceptable vehicle.


Patent
Sun Pharma Advanced Research Company | Date: 2015-06-25

The present invention relates to a parenteral pharmaceutical composition comprising therapeutically effective amounts of N-(2-pyrazine) carbonyl-L-phenylalanine-L-leucine boronic acid or its salts or its derivatives and tromethamine wherein the composition is stable.

Loading Sun Pharma Advanced Research Co. collaborators
Loading Sun Pharma Advanced Research Co. collaborators